View Older Stories View More Recent Stories

Jan 23, 2025 05:53AM BofA Adjusts US 1 List
Jan 23, 2025 05:18AM Eli Lilly & Co. (LLY) call put ratio 2.1 calls to 1 put
Jan 21, 2025 04:51AM BofA Securities Reiterates Buy Rating on Novo Nordisk (NOVOB:DC) (NVO)
Jan 17, 2025 09:44AM Leerink Partners Reiterates Outperform Rating on Eli Lilly (LLY)
Jan 17, 2025 07:11AM Eli Lilly (LLY) PT Lowered to $973 at Guggenheim
Jan 15, 2025 04:07PM Eli Lilly & Co. (LLY) Announces FDA Approval of Omvoh for Crohn's disease
Jan 15, 2025 10:24AM Bernstein SocGen Group Reiterates Outperform Rating on Eli Lilly (LLY) Despite 'Disappointing' GLP-1 Miss
Jan 15, 2025 05:24AM BMO Capital Reiterates Outperform Rating on Eli Lilly (LLY)
Jan 15, 2025 04:59AM Wells Fargo Reiterates Overweight Rating on Eli Lilly (LLY)
Jan 15, 2025 04:58AM BofA Securities on Eli Lilly (LLY): 'a particularly good buying opportunity'
Jan 15, 2025 04:54AM Citi Reiterates Buy Rating on Eli Lilly (LLY)
Jan 15, 2025 04:51AM Eli Lilly & Co. (LLY) call put ratio 1.4 calls to 1 put as share price pulls back
Jan 14, 2025 09:01AM Lilly (LLY) provides update on 2024 revenue guidance, announces 2025 revenue guidance
Jan 13, 2025 01:20PM Eli Lilly & Co. (LLY) Asks Biden Administration to Pause Drug-price Negotiation - Bloomberg
Jan 13, 2025 11:14AM Bernstein Weighs in on US Biopharma Sector in 2025; Highlights LLY as Top-pick
Jan 13, 2025 09:01AM Lilly (LLY) to acquire Scorpion Therapeutics' mutant-selective PI3Kα inhibitor program
Jan 10, 2025 01:34PM Eli Lilly (LLY) in advanced talks to buy US cancer biotech for up to $2.5bn - FT
Jan 8, 2025 03:32PM Medicare can now cover Eli Lilly’s (LLY) Zepbound for sleep apnea, CMS says - CNBC
Jan 8, 2025 10:14AM Truist Securities Reiterates Buy Rating on Eli Lilly (LLY); ' Near-term, It's All About GLP-1/Obesity'
Jan 2, 2025 12:39PM TD Cowen on Trump Tariffs and Other Risks: 'Where Does Pharma Stand?'
Dec 23, 2024 01:39PM Eli Lilly & Co. (LLY) commends ITC ruling cracking down on the unlawful importation and sale of knock-off tirzepatide products that put Americans at risk
Dec 23, 2024 09:58AM Piper Sandler on HGNS Devices Following Eli Lilly's Zepbound FDA Indication Approval
Dec 23, 2024 05:30AM KeyBanc Weighs in on GLP-1 Injection Leaders Following Latest NVO Results
Dec 20, 2024 10:59AM Eli Lilly & Co. (LLY) call put ratio 1.8 calls to 1 put after Novo Nordisk (NVO) released Cagrisema data
Dec 20, 2024 08:43AM Citi Reiterates Buy Rating on Eli Lilly (LLY)
Dec 20, 2024 07:13AM Viking Therapeutics (VKTX), Others Gain After Novo Nordisk (NVO) Data Falls Short of Expectations
Dec 20, 2024 06:23AM Bernstein Reiterates Outperform Rating on Eli Lilly (LLY); 'Lilly's Tirzepatide is Officially "No Longer in Shortage"'
Dec 20, 2024 05:39AM Eli Lilly & Co. (LLY) option IV bid into end of year
Dec 19, 2024 09:13AM Hims & Hers Health (HIMS) Quickly Falls 9% after FDA Says the Obesity Drug Shortage Ended
Dec 17, 2024 08:01PM Eli Lilly & Co. (LLY) Kisunla Approved in China for Treatment of Early Symptomatic Alzheimer's Disease
Dec 17, 2024 06:16AM Eli Lilly & Co. (LLY) and EVA Pharma announce regulatory approval and release of locally manufactured insulin in Egypt
Dec 15, 2024 06:57PM Innovent and Eli Lilly Expand Collaboration
Dec 13, 2024 10:56AM Ozempic Study Found Small Number Of Patients With Vision Loss - Bloomberg
Dec 13, 2024 08:12AM Eli Lilly's (LLY) Omvoh recommended by CHMP for approval in EU
Dec 13, 2024 06:32AM Bernstein: 'GLP-1s vs. the Weight of the World'
Dec 12, 2024 06:23AM Bernstein Sees Eli Lilly (LLY) 'In a Strong Position to Work Creatively With the New Administration'
Dec 11, 2024 09:44AM Truist: 'Potential Impact of Trump's Nominees on Biopharma'
Dec 11, 2024 08:16AM Eli Lilly & Co. (LLY) Reports Imlunestrant Significantly Improved Progression-Free Survival as Monotherapy and in Combination with Verzenio
Dec 11, 2024 08:13AM Hims & Hers Health, Inc. (HIMS) falls 7% as Ro says it is working with Eli Lilly to streamline access to Zepbound
Dec 9, 2024 04:49PM After-hours movers: Oracle, MongoDB, C3 AI, Lilly and more
Dec 9, 2024 04:19PM Eli Lilly & Co. (LLY) Raises Quarterly Dividend 15.4% to $1.50; 0.7% Yield
Dec 9, 2024 04:17PM Lilly (LLY) announces new $15 billion share repurchase program and seventh consecutive 15% dividend increase
Dec 9, 2024 07:00AM Bernstein: 'Could the lion's share of China GLP-1 market go to domestic players?'
Dec 5, 2024 03:30PM Lilly (LLY) announces $3 billion expansion of its recently acquired manufacturing facility in Wisconsin
Dec 5, 2024 12:03PM Trump hosted the chief executives of Pfizer (PFE), Eli Lilly & Co. (LLY) - Axios
Dec 5, 2024 11:54AM Zepbound vs Wegovy: 'Eli Lilly reinforces its (expected) superiority'
Dec 4, 2024 08:50AM BMO Capital: Five Key BioPharma Catalysts Through Year-End '24
Dec 4, 2024 06:46AM Eli Lilly & Co's (LLY) Zepbound superior to Wegovy in head-to-head trial showing an average weight loss of 20.2% vs. 13.7%
Dec 2, 2024 02:46PM Lilly Products Show Strength Heading Into the Holiday
Nov 30, 2024 04:00AM Is Trump 2.0 good or bad for healthcare stocks?
View More Recent Stories View Older Stories